AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittram, C.
Right arrow Articles by Shepard, J.-A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittram, C.
Right arrow Articles by Shepard, J.-A. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2003; 180:519-522
© American Roentgen Ray Society


Original Report

Thymic Enlargement and FDG Uptake in Three Patients: CT and FDG Positron Emission Tomography Correlated with Pathology

Conrad Wittram1, Allan J. Fischman1, Eugene Mark2, Jane Ko3 and Jo-Anne O. Shepard1

1 Department of Radiology, Massachusetts General Hospital and Harvard University, 55 Fruit St., Boston, MA 02114.
2 Department of Pathology, Massachusetts General Hospital and Harvard University, Boston, MA 02114.
3 Department of Radiology, Thoracic Imaging, New York University, 560 1st Ave., New York, NY 10016.

Received June 14, 2002; accepted after revision July 30, 2002.

 
Address correspondence to C. Wittram.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. Our purpose was to describe three adult patients in whom we found increased thymic uptake of FDG on positron emission tomography and thymic enlargement with convex lateral margins on CT. Subsequent biopsy or resection showed normal thymic tissue.

CONCLUSION. In three adults, we found a physiologic uptake of FDG by the thymus with standardized uptake values in the range of thymic neoplasia.


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
FDG positron emission tomography (PET) offers important functional information regarding tissue glucose metabolism and depicts hypermetabolic tissue. FDG PET is important in imaging oncology patients; for example, in the staging of mediastinal disease from non—small cell lung cancer, a sensitivity and specificity of 79% and 91%, respectively, has been reported [1]. After treatment for non—small cell lung cancer, a positive finding on FDG PET is a poor prognostic indicator [2]. It has been suggested that the thymus normally takes up FDG in children and adults [3,4,5]. However, to our knowledge, there has been no study with pathologic confirmation. Our purpose was to evaluate and correlate CT, FDG PET, and pathologic findings in three patients.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
This retrospective study was approved by our institutional review board. Our study included three women who were 29-44 years old (average age, 35 years), all of whom had confirmed normal thymic tissue and available FDG PET and CT scans. All patients were asymptomatic with respect to the chest. A mediastinal abnormality was detected on a chest radiograph and confirmed on CT in one patient and on staging chest CT in two patients. Two patients had a history of malignancy: one patient had breast carcinoma treated with mastectomy, axillary node dissection, and chemotherapy comprising cyclophosphamide, doxorubicine, and paclitaxel; the second patient had a prosthesis placed in the right hip and radiotherapy for the treatment of a solitary metastatic deposit of malignant melanoma.

A LightSpeed CT scanner (General Electric Medical Systems, Milwaukee, WI) was used to acquire the images from the lung apices to the kidneys with a 5-mm slice thickness, 15-mm table feed, and 0.8 sec/rotation. These scans were obtained during the IV injection of 100 mL of ioxilan 300 mg I/mL at the rate of 2 mL/sec using a power injector (MCT Plus; Medrad, Pittsburgh, PA). The scanning parameters were 140 kVp and 250 mA in two patients and 220 mA in one patient. Images were reviewed on lung window settings (window width, 1500 H; window level, -600 H) and mediastinal windows settings (window width, 350 H; window level, 40 H) on a PACS (picture archiving and communication system) monitor (IMPAX version 4.1; Agfa, Teterboro, NJ).

FDG PET images were obtained 5-21 days (average, 10 days) after the CT scans. The FDG PET studies were performed with a CT/i HR PET camera (Siemens Systems, Knoxville, TN) 45 min after IV injection of 15.5-17.5 mCi (573.5-647.5 MBq; average, 16.4 mCi [606.8 MBq]) of FDG. Attenuation correction was performed from transmission images acquired using a pin source containing germanium-68.

From 1 to 5 weeks after the FDG PET studies were performed (average, 3 weeks), two patients underwent mediastinotomy and thymus resection. One patient had a mediastinoscopy and biopsy of the right lobe of the thymus. Pathologic specimens were available in all patients and were reviewed by an experienced lung pathologist.

CT and FDG PET images were assessed retrospectively by two chest radiologists and a nuclear medicine physician. Decisions concerning the findings were reached by consensus. The CT analysis included the location, size, shape, margins, and internal characteristics of the bilobed structures. The longest and shortest perpendicular CT measurements were recorded. Thymic thickness was measured perpendicular to the length of the lobe [6, 7]. The standardized uptake value (SUV) was calculated in each case using a region of interest that included the highest activity area of the thymus but not covering the entire thymus. The SUV was determined as the concentration of FDG in the thymus divided by the injected radioactivity per gram of body weight.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
On CT, all patients showed a soft-tissue density in the location of the thymus (Figs. 1A,1B,1C,1D,2A,2B,3A,3B). One patient showed soft tissue extending superiorly among the left brachiocephalic vein, right brachiocephalic artery, and left common carotid arteries to the level of the thyroid gland (Fig. 1A,1B,1C,1D). The maximum measurement of the thymuses was 3.9-6.5 cm (average, 4.9 cm), and the shortest measurement was 2-3.5 cm (average, 2.9 cm). The maximum thickness of the thymuses was 1.5-1.9 cm (average, 1.7 cm). The bilobed structures revealed ill-defined margins in two patients and slightly lobulated margins in one patient. The thymuses appeared to have small flecks of fat in them.



View larger version (110K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. Thymic enlargement in 29-year-old woman. Contrast-enhanced CT scan of thorax obtained at level of left brachiocephalic vein shows soft tissue (arrow) among left brachiocephalic vein anteriorly, superior vena cava laterally, and right brachiocephalic artery and left common carotid artery posteriorly.

 


View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. Thymic enlargement in 29-year-old woman. Axial FDG positron emission tomography (PET) scan obtained at same level as A shows increase in uptake of FDG in soft tissue (arrows) compared with mediastinum.

 


View larger version (105K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C. Thymic enlargement in 29-year-old woman. Contrast-enhanced CT scan obtained at level of aortic arch shows thickness of thymus to be 1.5 cm. Note convex lateral margin.

 


View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D. Thymic enlargement in 29-year-old woman. Axial FDG PET scan obtained at same level as C shows increase in uptake of FDG in thymus (arrow).

 


View larger version (101K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. Thymic enlargement in 44-year-old woman with history of malignant melanoma. Contrast-enhanced CT scan of thorax obtained at level of carina shows soft tissue in region of thymus. Left lobe of thymus measures 1.7 cm in thickness and has slight convex lateral margin.

 


View larger version (90K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. Thymic enlargement in 44-year-old woman with history of malignant melanoma. Axial FDG positron emission tomography scan obtained at same level as A shows increase in uptake of FDG in thymus (arrows).

 


View larger version (136K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A. Thymic enlargement in 32-year-old woman with history of breast cancer. Contrast-enhanced CT scan of thorax obtained at level of aortic arch shows soft tissue in region of thymus. Left and right lobes of thymus measure 2.1 cm and 1 cm in thickness, respectively, and have convex lateral margins. Note left breast mass.

 


View larger version (87K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B. Thymic enlargement in 32-year-old woman with history of breast cancer. Axial FDG positron emission tomography scan shows increase in uptake of FDG in thymus.

 

All FDG PET scans depicted increased uptake of FDG in the anterior mediastinum corresponding to the anterior mediastinal soft-tissue opacity seen on CT. The SUVs ranged from 1.1 to 2.2 (average, 1.8 ± 0.55).

Histologic examination in all three patients revealed normal-appearing cortex, medulla, and Hassall's corpuscles, with no evidence of malignancy.


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The normal thymus is a bilobed structure fused superiorly near the thyroid gland and molded smoothly to the anterior aspect of the great vessels; the normal thymusextends inferiorly to the base of the heart. On CT, normal measurements of the thymus have been reported; the most useful value for thymic size is thickness measured perpendicular to the length of a lobe. In patients younger than 20 years, a thickness of 1.8 cm is considered the maximal allowable normal value, with 1.3 cm being the maximal normal value in older subjects [6, 7]. In adults, the borders of the thymus are typically flat or concave laterally [6, 7].

In this series, the histology of all three thymic specimens was normal. However, in each patient, the thickness of the thymus exceeded 13 mm [6, 7]. Therefore, these patients showed thymic enlargement. Interestingly, findings in all the patients revealed slight convexity of the thymus, particularly affecting the left lobe of the thymus seen on CT. Figure 1A,1B,1C,1D displays an anatomic variant of the thymus, with thymic tissue revealed in the superior mediastinum among the left brachiocephalic vein, right brachiocephalic artery, and left common carotid arteries.

Embryologically, the thymus originates from the third branchial pouch. This endothelial tissue migrates from the pharynx to the anterior mediastinum during embryogenesis; therefore, thymic tissue can remain at any point along this path. In a surgical—anatomic study of 50 consecutive patients, the variant seen in a 29-year-old woman in our study was identified in one patient [8].

The cause of thymic enlargement in a 32-year-old woman in our study was likely related to thymic regrowth in response to chemotherapy. In a CT evaluation by Choyke et al. [9] of thymic atrophy and regrowth in response to chemotherapy, three patients with thymic enlargement, like the patients in our study, had normal findings at histology. The cause of thymic enlargement seen on CT in our study in 29- and 44-year-old patients is unknown.

In a study by Nakahara et al. [5], increased FDG uptake was found in 32 of 94 adult patients (range, 18-29 years; mean age, 25.4 years) who had normal-appearing thymuses on CT. These patients had no symptoms suggestive of thymus-related disease or mediastinal tumor. These subjects had normal clinical follow-up periods ranging from 6 to 69 months; however, there was no histologic correlation. Nakahara et al. suggested that the upper age limit of normal FDG uptake in the thymus is 29 years. However, two of our patients were 32 and 44 years old, indicating normal thymic FDG uptake can occur in older patients. To our knowledge, there is only one previous case report of an adult patient with uptake of FDG in the thymus and biopsy-proven normal thymic tissue: a 54-year-old woman with a history of recurrent thyroid follicular cancer treated with a high dose of iodine-131 therapy [10]. The case report by Alibazoglu et al. [10] supports our observations of physiologic uptake of FDG in the thymus in adults. To the best of our knowledge, ours is the only series of patients in whom an increase in uptake of FDG in the thymus has been correlated with CT and pathologic examination.

In a study by Sasaki et al. [11], 31 patients with histologically proven thymic tumors were evaluated with FDG PET. In their study, the SUVs for 14 patients with thymic cancer (mean ± SD, 7.2 ± 2.9) were higher than those of nine patients with invasive thymoma (3.8 ± 1.3), five patients with noninvasive thymoma (3.0 ± 1.0), and three patients with thymic cysts (0.9). In our study, the mean SUV of normal thymic tissue was 1.8 ± 0.55, which overlaps with the values obtained for thymomas in the article by Sasaki et al. The SUV is subject to many sources of variability, including body composition and habitus, the period of FDG uptake, plasma glucose value, recovery coefficient, and partial volume effects. These factors can cause potential errors of 50% or more [12]. Therefore, one must consider these numbers as a guide and not as an absolute.

In summary, enlargement of the thymus, as seen on CT, is also manifest with convex lateral borders. An increase in FDG uptake in adults can be seen in normal thymic tissue, and the degree of FDG uptake by the thymus overlaps the values of thymic neoplasia.


Acknowledgments
 
We thank Anne-Marie Reardon for preparation of this manuscript.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non—small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology 1999;213:530 -536[Abstract/Free Full Text]
  2. Patz EF Jr, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non—small cell lung cancer. AJR 2000;174:769 -774[Abstract/Free Full Text]
  3. Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 1996;21:772 -775[Medline]
  4. Brink I, Reinhardt J, Hoegerle S, Altehoefer C, Moser E, Nitzsche EU. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 2001;42:591 -595[Abstract/Free Full Text]
  5. Nakahara T, Fujii H, Ide M, et al. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Br J Radiol 2001;74:821 -824[Abstract/Free Full Text]
  6. Francis IR, Glazer GM, Bookstein FL, Gross BH. The thymus: reexamination of age-related changes in size and shape. AJR 1985;145:249 -254[Abstract/Free Full Text]
  7. Nicolaou S, Muller NL, Li DKB, Oger JJF. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology 1996;201:471 -474[Abstract/Free Full Text]
  8. Jaretzki A 3rd, Wolff M. "Maximal" thymectomy for myasthenia gravis: surgical anatomy and operative technique. J Thorac Cardiovas Surg 1988;96:711 -716[Abstract]
  9. Choyke PL, Zeman RK, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. AJR 1987;149:269 -272[Abstract/Free Full Text]
  10. Alibazoglu H, Alibazouglu B, Hollinger EF, et al. Normal thymic uptake of 2-deoxy-2 [F-18] fluoro-D-glucose. Clin Nucl Med 1999;24:597 -600[Medline]
  11. Sasaki M, Kuwabara Y, Ichiya Y, et al. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med 1999;40:1595 -1601[Abstract/Free Full Text]
  12. Keyes JW. SUV: standard uptake or silly useless values? J Nucl Med 1995;36:1836 -1839[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Ferolla, A. Falchetti, P. Filosso, P. Tomassetti, G. Tamburrano, N. Avenia, G. Daddi, F. Puma, R. Ribacchi, F. Santeusanio, et al.
Thymic Neuroendocrine Carcinoma (Carcinoid) in Multiple Endocrine Neoplasia Type 1 Syndrome: The Italian Series
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2603 - 2609.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
B. Ferdinand, P. Gupta, and E. L. Kramer
Spectrum of Thymic Uptake at 18F-FDG PET
RadioGraphics, November 1, 2004; 24(6): 1611 - 1616.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. B. Flieder, S. K. Vora, A. Sanders, and B. Gelbman
Benign Thymic Hyperplasia As a Cause of Anterior Mediastinal Mass After Chemotherapy
Chest Meeting Abstracts, October 1, 2004; 126(4): 929S - 929S.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Younes-Mhenni, M. F. Janier, L. Cinotti, J. C. Antoine, F. Tronc, V. Cottin, P. J. Ternamian, P. Trouillas, and J. Honnorat
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes
Brain, October 1, 2004; 127(10): 2331 - 2338.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittram, C.
Right arrow Articles by Shepard, J.-A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittram, C.
Right arrow Articles by Shepard, J.-A. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS